BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2021
View Archived Issues
Enobosarm confers clinical benefit in patients with AR+/ER+ metastatic breast cancer
Read More
ChemoCentryx describes new PD-1/PD-L1 interaction inhibitors
Read More
Stanford University presents new anticancer peptides
Read More
New antibacterials discovered at Wockhardt
Read More
TroBio Therapeutics identifies new tropomyosin alpha-3 chain inhibitors
Read More
AAV9 encoding NPC intracellular cholesterol transporter 1 synthesized at StrideBio
Read More
TRPV1 antagonist SAF-312 reduces pain after photorefractive keratectomy
Read More
Natural language processing identifies impact of diazoxide choline on Prader-Willi syndrome
Read More
Anti-CD3 DARPin T-cell engager is active only in the tumor microenvironment
Read More
IMV to initiate phase Ib study of maveropepimut-S in breast cancer
Read More
Checkmate and Regeneron enter agreement to evaluate vidutolimod plus cemiplimab
Read More
Diffusion reports final data from phase Ib study of TSC in hospitalized COVID-19 patients
Read More
Key interim analysis findings from phase Ia/Ib monotherapy study of CUE-101 in HNSCC
Read More
G1 Therapeutics initiates phase II PRESERVE 4 study of trilaciclib in NSCLC
Read More
First patient dosed in phase I/II study of CBX-12 in advanced or metastatic refractory solid tumors
Read More
GBR-830 shows improvement at 16 weeks in patients with moderate to severe atopic dermatitis
Read More
Novel progression risk tissue markers in premalignant cervical lesions
Read More
Ascendis reports 58-week data from phase II OLE study of TransCon PTH in hypoparathyroidism
Read More
FDA authorizes Pfizer and BioNTech's COVID-19 vaccine for adolescents aged 12-15 years
Read More
Gavo-cel shows promising phase I/II results in patients with mesothelin-overexpressing solid tumors
Read More
Hamlet Pharma reports dose-escalation data on Alpha-1H in bladder cancer
Read More
Phase I trial of Ampion in long COVID receives IRB approval
Read More
Enrollment opens in phase II study of BA-3011 for metastatic NSCLC
Read More
New phase I trial evaluates PBCAR-19B in CD19-expressing malignancies
Read More
SARS-CoV-2 vaccines make progress in the young, the old, the in-between
Read More